ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma

Purpose. To investigate the expression of LPCAT1 in liver hepatocellular carcinoma (LIHC) and its relationship with prognosis and immune infiltration and predict its upstream nonencoding RNAs (ncRNAs). Method. In this study, expression analysis and survival analysis for LPCAT1 in pan cancers were fi...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiu Sun, Xudong Liu, Qunlong Peng, Lei Hu, Xiaochun Jiang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/1584397
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565817481363456
author Qiu Sun
Xudong Liu
Qunlong Peng
Lei Hu
Xiaochun Jiang
author_facet Qiu Sun
Xudong Liu
Qunlong Peng
Lei Hu
Xiaochun Jiang
author_sort Qiu Sun
collection DOAJ
description Purpose. To investigate the expression of LPCAT1 in liver hepatocellular carcinoma (LIHC) and its relationship with prognosis and immune infiltration and predict its upstream nonencoding RNAs (ncRNAs). Method. In this study, expression analysis and survival analysis for LPCAT1 in pan cancers were first performed by using The Cancer Genome Atlas (TCGA) data, which suggested that LPCAT1 might be a potential LIHC oncogene. Then, ncRNAs contributing to the overexpression of LPCAT1 were explored in starBase by a combination of expression analysis, correlation analysis, and survival analysis. Immune cell infiltration of LPCAT1 in LIHC was finally investigated via Tumor Immune Estimation Resource (TIMER). Result. SNHG3 was observed to be the most promising upstream lncRNA for the hsa-miR-139-5p/LPCAT1 axis in LIHC. In addition, the LPCAT1 level was significantly positively associated with tumor immune cell infiltration, biomarkers of immune cells, and immune checkpoint expression in LIHC. Conclusion. To summarize, the upregulation of LPCAT1 mediated by ncRNAs is associated with poor prognosis, immune infiltration, and immune checkpoint expression in LIHC.
format Article
id doaj-art-d0234b7498e04d9c999fd1530e745c77
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-d0234b7498e04d9c999fd1530e745c772025-02-03T01:06:35ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/1584397ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular CarcinomaQiu Sun0Xudong Liu1Qunlong Peng2Lei Hu3Xiaochun Jiang4Heilongjiang University of Chinese MedicineHeilongjiang University of Chinese MedicineCollege of PharmacyAnhui Medical UniversityHeilongjiang University of Chinese MedicinePurpose. To investigate the expression of LPCAT1 in liver hepatocellular carcinoma (LIHC) and its relationship with prognosis and immune infiltration and predict its upstream nonencoding RNAs (ncRNAs). Method. In this study, expression analysis and survival analysis for LPCAT1 in pan cancers were first performed by using The Cancer Genome Atlas (TCGA) data, which suggested that LPCAT1 might be a potential LIHC oncogene. Then, ncRNAs contributing to the overexpression of LPCAT1 were explored in starBase by a combination of expression analysis, correlation analysis, and survival analysis. Immune cell infiltration of LPCAT1 in LIHC was finally investigated via Tumor Immune Estimation Resource (TIMER). Result. SNHG3 was observed to be the most promising upstream lncRNA for the hsa-miR-139-5p/LPCAT1 axis in LIHC. In addition, the LPCAT1 level was significantly positively associated with tumor immune cell infiltration, biomarkers of immune cells, and immune checkpoint expression in LIHC. Conclusion. To summarize, the upregulation of LPCAT1 mediated by ncRNAs is associated with poor prognosis, immune infiltration, and immune checkpoint expression in LIHC.http://dx.doi.org/10.1155/2022/1584397
spellingShingle Qiu Sun
Xudong Liu
Qunlong Peng
Lei Hu
Xiaochun Jiang
ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma
Journal of Immunology Research
title ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma
title_full ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma
title_fullStr ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma
title_full_unstemmed ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma
title_short ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma
title_sort ncrna mediated high expression of lpcat1 correlates with poor prognosis and tumor immune infiltration of liver hepatocellular carcinoma
url http://dx.doi.org/10.1155/2022/1584397
work_keys_str_mv AT qiusun ncrnamediatedhighexpressionoflpcat1correlateswithpoorprognosisandtumorimmuneinfiltrationofliverhepatocellularcarcinoma
AT xudongliu ncrnamediatedhighexpressionoflpcat1correlateswithpoorprognosisandtumorimmuneinfiltrationofliverhepatocellularcarcinoma
AT qunlongpeng ncrnamediatedhighexpressionoflpcat1correlateswithpoorprognosisandtumorimmuneinfiltrationofliverhepatocellularcarcinoma
AT leihu ncrnamediatedhighexpressionoflpcat1correlateswithpoorprognosisandtumorimmuneinfiltrationofliverhepatocellularcarcinoma
AT xiaochunjiang ncrnamediatedhighexpressionoflpcat1correlateswithpoorprognosisandtumorimmuneinfiltrationofliverhepatocellularcarcinoma